Literature DB >> 16900762

Sleep and fatigue in multiple sclerosis.

B R Stanton1, F Barnes, E Silber.   

Abstract

Fatigue is common in multiple sclerosis (MS) and is an important cause of disability. However, the cause of fatigue is poorly understood. This study aimed to describe the frequency and pattern of sleep disturbance in a group of outpatients with MS, and to investigate the relationship between sleep disturbance and fatigue. Sixty outpatients with MS completed the Fatigue Severity Scale (FSS) and the Epworth Sleepiness Scale and kept a sleep diary for seven days. Fatigue and excessive daytime sleepiness were common in this group of patients (64 and 32%). Sleep problems on at least two nights per week occurred frequently, including initial insomnia in 42%, middle insomnia in 53% and terminal insomnia in 58%. The reasons cited for different types of insomnia varied, with anxiety and pain/discomfort being the commonest causes of initial insomnia and nocturia the commonest cause of middle insomnia. Middle insomnia was significantly correlated with daytime fatigue, a relationship that remained after controlling for disability. Sleep disturbance is common in MS and is associated with treatable symptoms, including pain and nocturia. Sleep disturbance may be an important factor contributing to fatigue in patients with MS.

Entities:  

Mesh:

Year:  2006        PMID: 16900762     DOI: 10.1191/135248506ms1320oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  54 in total

1.  Sleepiness, fatigue, and risk of obstructive sleep apnea using the STOP-BANG questionnaire in multiple sclerosis: a pilot study.

Authors:  Robert A Dias; Kimberly A Hardin; Heather Rose; Mark A Agius; Michelle L Apperson; Steven D Brass
Journal:  Sleep Breath       Date:  2012-01-21       Impact factor: 2.816

2.  Psychometric properties of the Hamilton Depression Rating Scale in multiple sclerosis.

Authors:  Simona Raimo; Luigi Trojano; Daniele Spitaleri; Vittorio Petretta; Dario Grossi; Gabriella Santangelo
Journal:  Qual Life Res       Date:  2015-02-11       Impact factor: 4.147

3.  Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women.

Authors:  Y Li; K L Munger; S Batool-Anwar; K De Vito; A Ascherio; X Gao
Journal:  Neurology       Date:  2012-04-25       Impact factor: 9.910

4.  Monitoring my multiple sclerosis: a patient-administered health-assessment scale.

Authors:  Elsie E Gulick; Marie Namey; June Halper
Journal:  Int J MS Care       Date:  2011

5.  Sleep disorders in patients with multiple sclerosis in China.

Authors:  Shengli Ma; Xue Rui; Peiyi Qi; Gangqiong Liu; Jing Yang
Journal:  Sleep Breath       Date:  2016-10-11       Impact factor: 2.816

6.  Evaluation of the effect of progressive relaxation exercises on fatigue and sleep quality in patients with multiple sclerosis.

Authors:  Nuray Dayapoğlu; Mehtap Tan
Journal:  J Altern Complement Med       Date:  2012-09-11       Impact factor: 2.579

7.  The underdiagnosis of sleep disorders in patients with multiple sclerosis.

Authors:  Steven D Brass; Chin-Shang Li; Sanford Auerbach
Journal:  J Clin Sleep Med       Date:  2014-09-15       Impact factor: 4.062

Review 8.  Sleep Abnormalities in Multiple Sclerosis.

Authors:  Giorgos K Sakkas; Christoforos D Giannaki; Christina Karatzaferi; Mauro Manconi
Journal:  Curr Treat Options Neurol       Date:  2019-01-31       Impact factor: 3.598

9.  Low Prevalence of Sleep Disorders in Demyelinating Disease in a Northern Tenerife Population.

Authors:  Montserrat González-Platas; Javier González-Platas; Moises Bermúdez-Hernández; Maria Yaiza Pérez-Martín; Cristina Croissier-Elías; Pedro Javier Pérez-Lorensu
Journal:  J Clin Sleep Med       Date:  2016-06-15       Impact factor: 4.062

10.  Beyond fatigue: Assessing variables associated with sleep problems and use of sleep medications in multiple sclerosis.

Authors:  Alyssa M Bamer; Kurt L Johnson; Dagmar A Amtmann; George H Kraft
Journal:  Clin Epidemiol       Date:  2010-05-01       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.